- Home
- BPRN vs CRVS Comparison
BPRN vs CRVS Comparison
Compare BPRN & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPRN
- CRVS
- Stock Information
- Founded
- BPRN 2007
- CRVS 2014
- Country
- BPRN United States
- CRVS United States
- Employees
- BPRN 249
- CRVS N/A
- Industry
- BPRN Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- BPRN Finance
- CRVS Health Care
- Exchange
- BPRN Nasdaq
- CRVS Nasdaq
- Market Cap
- BPRN 196.7M
- CRVS 206.5M
- IPO Year
- BPRN N/A
- CRVS 2016
- Fundamental
- Price
- BPRN $28.24
- CRVS $3.63
- Analyst Decision
- BPRN Strong Buy
- CRVS Strong Buy
- Analyst Count
- BPRN 1
- CRVS 3
- Target Price
- BPRN $35.00
- CRVS $15.67
- AVG Volume (30 Days)
- BPRN 10.4K
- CRVS 906.6K
- Earning Date
- BPRN 04-24-2025
- CRVS 05-05-2025
- Dividend Yield
- BPRN 4.13%
- CRVS N/A
- EPS Growth
- BPRN N/A
- CRVS N/A
- EPS
- BPRN 1.67
- CRVS N/A
- Revenue
- BPRN $73,010,000.00
- CRVS N/A
- Revenue This Year
- BPRN $13.29
- CRVS N/A
- Revenue Next Year
- BPRN $16.39
- CRVS N/A
- P/E Ratio
- BPRN $17.44
- CRVS N/A
- Revenue Growth
- BPRN 6.10
- CRVS N/A
- 52 Week Low
- BPRN $27.25
- CRVS $1.43
- 52 Week High
- BPRN $39.35
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- BPRN 40.06
- CRVS 55.04
- Support Level
- BPRN $27.85
- CRVS $3.15
- Resistance Level
- BPRN $29.98
- CRVS $3.78
- Average True Range (ATR)
- BPRN 1.06
- CRVS 0.25
- MACD
- BPRN 0.12
- CRVS 0.12
- Stochastic Oscillator
- BPRN 28.86
- CRVS 87.90
About BPRN Princeton Bancorp Inc. (PA)
Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).